research

In the Lab Deborah Balthazar

With placenta-on-a-chip, researchers hope to gauge how drugs and toxins impact pregnancy

Pharma Jason Mast

STAT Plus: Pfizer’s gene therapy for Duchenne muscular dystrophy fails in Phase 3 trial

The Readout Elaine Chen

STAT Plus: What do Parkinson’s and obesity have in common?

In the Lab Rohan Rajeev

Three scientists win Kavli Prize for nanoscience in biomedicine

Politics Sarah Owermohle

STAT Plus: House Republicans press for new guardrails on ‘gain-of-function’ research by NIH

The Readout Elaine Chen

Eli Lilly’s Alzheimer’s candidate, Bob Langer’s new startup, and other biotech news you need to know

Health tech Lizzy Lawrence

STAT Plus: Medical device trials still don’t enroll enough women, study finds

The Readout Meghana Keshavan

The biotech news you missed from the weekend

Health Annalisa Merelli

NIH will bring clinical research into primary care offices with $30 million pilot

The Readout Meghana Keshavan

STAT Plus: Vanda Pharmaceuticals has another suitor

In the Lab Jonathan Wosen

STAT Plus: Stephen Quake on the Chan Zuckerberg quest to cure, prevent, or manage all diseases by 2100

The Readout Elaine Chen

Novavax will be able to supply Covid-19 vaccines this fall

Health Annalisa Merelli

Withdrawal symptoms hit one in six patients stopping antidepressants, review finds

First Opinion Eran Bendavid and Chirag Patel

100,000 models show that not much was learned about stopping the Covid-19 pandemic

The Readout Jason Mast

STAT Plus: Testing begins for a new form of PrEP

Biotech Adam Feuerstein, Matthew Herper, and Angus Chen

STAT Plus: ASCO Takeaways: Winners, snoozers, the China question, and the art of cancer care

The Readout Elaine Chen

STAT Plus: Operation Warp Speed but for rare disease

In the Lab Megan Molteni

A new discovery about carbon dioxide is challenging decades-old ventilation doctrine

Pharmalot Ed Silverman

STAT Plus: Leading CRO to pay record fine for badly neglecting hundreds of beagles in breeding facility

Biotech Angus Chen

STAT Plus: At ASCO, AstraZeneca says its CAR-T therapy shrank solid liver tumors in early trial

The Readout Meghana Keshavan

STAT Plus: Can AstraZeneca make good on its promise?

Health Olivia Goldhill

What to watch for in the crucial FDA meeting on MDMA therapy for PTSD

The Readout Meghana Keshavan

STAT Plus: The surprising outperformance of a new drug against existing competitors, and other biotech updates

Biotech Jonathan Wosen

STAT Plus: Ionis drug prevents swelling attacks caused by rare genetic disease in late-stage trials

Exclusive Betsy Ladyzhets

NIH documents show how $1.6 billion long Covid initiative has failed so far to meet its goals

The Readout Elaine Chen

STAT Plus: Biohaven’s autoimmune drug disappoints, and other biotech news updates from the week

In the Lab Nicholas Florko and Sarah Owermohle

What the rescheduling of marijuana might — and might not — mean for scientific research

Politics John Wilkerson

STAT Plus: NIH-funded clinical trials often miss racial, gender diversity enrollment goals, report finds

The Readout Elaine Chen

STAT Plus: Wegovy linked to lower risk of alcohol use disorder in real-world study